in this issue
Regions :: North America
Aceto earnings rise on strong pharma business
3:32 PM MDT | August 28, 2013 | Vincent Valk
Aceto’s (Port Washington, NY) fiscal fourth-quarter net income was up 35.7% year-on-year (YOY), to $5.4 million, or 19 cts/share, on sales up 11%, to $123.1 million, the company says. Adjusted net income totaled $5.6 million, or 20 cts/share, matching analysts’ consensus estimate as reported by Thomson Reuters (New York). Aceto’s fiscal fourth-quarter ended on 30 June. Sales increased in the company’s human health business, on new generic product launches and higher sales of nutritional supplements. Performance chemicals and pharmaceutical...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee